CLINICAL_TRIALS
trial_result
· 2016-06-09
Clinical Trial Update: Hypofractionated Stereotactic Body Radiation Therapy (SBRT) [Phase 2]
Summary
Phase 2 trial evaluating hypofractionated stereotactic body radiation therapy for prostate cancer has completed; results were posted in June 2016.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: University of Michigan Rogel Cancer Center | Conditions: Prostate Cancer | Phase 2 | Status: COMPLETED | Results posted: 2016-06-09